Progression of lung disease in preschool patients with cystic fibrosis

Sanja Stanojevic, Stephanie Davis, George Retsch-Bogart, Hailey Webster, Miriam Davis, Robin C. Johnson, Renee Jensen, Maria Ester Pizarro, Mica Kane, Charles C. Clem, Leah Schornick, Padmaja Subbarao, Felix A. Ratjen

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Rationale: Implementation of intervention strategies to prevent lung damage in early cystic fibrosis (CF) requires objective outcome measures that capture and track lung disease. Objectives: To define the utility of the Lung Clearance Index (LCI), measured by multiple breath washout, as a means to track disease progression in preschool children with CF. Methods: Children with CF between the ages of 2.5 and 6 years with a confirmed diagnosis of CF and age-matched healthy control subjects were enrolled at three North American CF centers. Multiple breath washout tests were performed at baseline, 1, 3, 6, and 12 months to mimic time points chosen in clinical care and interventional trials; spirometry was also conducted. A generalized linear mixed-effects model was used to distinguish LCI changes associated with normal growth and development (i.e., healthy children) from the progression of CF lung disease. Measurements and Main Results: Data were collected on 156 participants with 800 LCI measurements. Although both LCI and spirometry discriminated health from disease, only the LCI identified significant deterioration of lung function in CF over time. The LCI worsened during cough episodes and pulmonary exacerbations, whereas similar symptoms in healthy children were not associated with increased LCI values. Conclusions: LCI is a useful marker to track early disease progression and may serve as a tool to guide therapies in young patients with CF.

Original languageEnglish (US)
Pages (from-to)1216-1225
Number of pages10
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume195
Issue number9
DOIs
StatePublished - May 1 2017

Fingerprint

Cystic Fibrosis
Lung Diseases
Lung
Spirometry
Disease Progression
Breath Tests
Preschool Children
Growth and Development
Cough
Healthy Volunteers
Outcome Assessment (Health Care)
Health

Keywords

  • Cystic fibrosis
  • Disease progression
  • Lung clearance index
  • Lung function

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Stanojevic, S., Davis, S., Retsch-Bogart, G., Webster, H., Davis, M., Johnson, R. C., ... Ratjen, F. A. (2017). Progression of lung disease in preschool patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 195(9), 1216-1225. https://doi.org/10.1164/rccm.201610-2158OC

Progression of lung disease in preschool patients with cystic fibrosis. / Stanojevic, Sanja; Davis, Stephanie; Retsch-Bogart, George; Webster, Hailey; Davis, Miriam; Johnson, Robin C.; Jensen, Renee; Pizarro, Maria Ester; Kane, Mica; Clem, Charles C.; Schornick, Leah; Subbarao, Padmaja; Ratjen, Felix A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 195, No. 9, 01.05.2017, p. 1216-1225.

Research output: Contribution to journalArticle

Stanojevic, S, Davis, S, Retsch-Bogart, G, Webster, H, Davis, M, Johnson, RC, Jensen, R, Pizarro, ME, Kane, M, Clem, CC, Schornick, L, Subbarao, P & Ratjen, FA 2017, 'Progression of lung disease in preschool patients with cystic fibrosis', American Journal of Respiratory and Critical Care Medicine, vol. 195, no. 9, pp. 1216-1225. https://doi.org/10.1164/rccm.201610-2158OC
Stanojevic, Sanja ; Davis, Stephanie ; Retsch-Bogart, George ; Webster, Hailey ; Davis, Miriam ; Johnson, Robin C. ; Jensen, Renee ; Pizarro, Maria Ester ; Kane, Mica ; Clem, Charles C. ; Schornick, Leah ; Subbarao, Padmaja ; Ratjen, Felix A. / Progression of lung disease in preschool patients with cystic fibrosis. In: American Journal of Respiratory and Critical Care Medicine. 2017 ; Vol. 195, No. 9. pp. 1216-1225.
@article{91bda77ffcc148629116e9449228474a,
title = "Progression of lung disease in preschool patients with cystic fibrosis",
abstract = "Rationale: Implementation of intervention strategies to prevent lung damage in early cystic fibrosis (CF) requires objective outcome measures that capture and track lung disease. Objectives: To define the utility of the Lung Clearance Index (LCI), measured by multiple breath washout, as a means to track disease progression in preschool children with CF. Methods: Children with CF between the ages of 2.5 and 6 years with a confirmed diagnosis of CF and age-matched healthy control subjects were enrolled at three North American CF centers. Multiple breath washout tests were performed at baseline, 1, 3, 6, and 12 months to mimic time points chosen in clinical care and interventional trials; spirometry was also conducted. A generalized linear mixed-effects model was used to distinguish LCI changes associated with normal growth and development (i.e., healthy children) from the progression of CF lung disease. Measurements and Main Results: Data were collected on 156 participants with 800 LCI measurements. Although both LCI and spirometry discriminated health from disease, only the LCI identified significant deterioration of lung function in CF over time. The LCI worsened during cough episodes and pulmonary exacerbations, whereas similar symptoms in healthy children were not associated with increased LCI values. Conclusions: LCI is a useful marker to track early disease progression and may serve as a tool to guide therapies in young patients with CF.",
keywords = "Cystic fibrosis, Disease progression, Lung clearance index, Lung function",
author = "Sanja Stanojevic and Stephanie Davis and George Retsch-Bogart and Hailey Webster and Miriam Davis and Johnson, {Robin C.} and Renee Jensen and Pizarro, {Maria Ester} and Mica Kane and Clem, {Charles C.} and Leah Schornick and Padmaja Subbarao and Ratjen, {Felix A.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1164/rccm.201610-2158OC",
language = "English (US)",
volume = "195",
pages = "1216--1225",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "9",

}

TY - JOUR

T1 - Progression of lung disease in preschool patients with cystic fibrosis

AU - Stanojevic, Sanja

AU - Davis, Stephanie

AU - Retsch-Bogart, George

AU - Webster, Hailey

AU - Davis, Miriam

AU - Johnson, Robin C.

AU - Jensen, Renee

AU - Pizarro, Maria Ester

AU - Kane, Mica

AU - Clem, Charles C.

AU - Schornick, Leah

AU - Subbarao, Padmaja

AU - Ratjen, Felix A.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Rationale: Implementation of intervention strategies to prevent lung damage in early cystic fibrosis (CF) requires objective outcome measures that capture and track lung disease. Objectives: To define the utility of the Lung Clearance Index (LCI), measured by multiple breath washout, as a means to track disease progression in preschool children with CF. Methods: Children with CF between the ages of 2.5 and 6 years with a confirmed diagnosis of CF and age-matched healthy control subjects were enrolled at three North American CF centers. Multiple breath washout tests were performed at baseline, 1, 3, 6, and 12 months to mimic time points chosen in clinical care and interventional trials; spirometry was also conducted. A generalized linear mixed-effects model was used to distinguish LCI changes associated with normal growth and development (i.e., healthy children) from the progression of CF lung disease. Measurements and Main Results: Data were collected on 156 participants with 800 LCI measurements. Although both LCI and spirometry discriminated health from disease, only the LCI identified significant deterioration of lung function in CF over time. The LCI worsened during cough episodes and pulmonary exacerbations, whereas similar symptoms in healthy children were not associated with increased LCI values. Conclusions: LCI is a useful marker to track early disease progression and may serve as a tool to guide therapies in young patients with CF.

AB - Rationale: Implementation of intervention strategies to prevent lung damage in early cystic fibrosis (CF) requires objective outcome measures that capture and track lung disease. Objectives: To define the utility of the Lung Clearance Index (LCI), measured by multiple breath washout, as a means to track disease progression in preschool children with CF. Methods: Children with CF between the ages of 2.5 and 6 years with a confirmed diagnosis of CF and age-matched healthy control subjects were enrolled at three North American CF centers. Multiple breath washout tests were performed at baseline, 1, 3, 6, and 12 months to mimic time points chosen in clinical care and interventional trials; spirometry was also conducted. A generalized linear mixed-effects model was used to distinguish LCI changes associated with normal growth and development (i.e., healthy children) from the progression of CF lung disease. Measurements and Main Results: Data were collected on 156 participants with 800 LCI measurements. Although both LCI and spirometry discriminated health from disease, only the LCI identified significant deterioration of lung function in CF over time. The LCI worsened during cough episodes and pulmonary exacerbations, whereas similar symptoms in healthy children were not associated with increased LCI values. Conclusions: LCI is a useful marker to track early disease progression and may serve as a tool to guide therapies in young patients with CF.

KW - Cystic fibrosis

KW - Disease progression

KW - Lung clearance index

KW - Lung function

UR - http://www.scopus.com/inward/record.url?scp=85018949572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018949572&partnerID=8YFLogxK

U2 - 10.1164/rccm.201610-2158OC

DO - 10.1164/rccm.201610-2158OC

M3 - Article

C2 - 27943680

AN - SCOPUS:85018949572

VL - 195

SP - 1216

EP - 1225

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 9

ER -